Manyan kamfanoni 10 na kasar Sin Biotech [Pharma]

An sabunta ta ƙarshe ranar 7 ga Satumba, 2022 da ƙarfe 01:28 na yamma

Anan za ku iya samun Jerin Manyan Kamfanonin Biotech [Pharma] na kasar Sin 10 da ke da Kudi, Kuɗi da Bayanan Bayanan Kowane Kamfani.

Jerin Manyan Kamfanonin Biotech [Pharma] 10 na kasar Sin

To ga List of

1. Guangzhou Baiyunshan Pharmaceutical Group

Guangzhou Baiyunshan Pharmaceutical Group Co., Ltd. shine kamfani da aka jera wanda Guangzhou Pharmaceutical Group Co., Ltd. (A hannun jari 600332, H hannun jari 00874), yafi tsunduma a:

1. Magungunan sinadarai na kasar Sin da na yammacin duniya, albarkatun kasa, magunguna na halitta, magungunan halittu, albarkatun sinadaran R&D, masana'antu da tallace-tallace na tsaka-tsaki;
2. Jama'a, retail da shigo da magunguna na yammacin duniya, magungunan gargajiya na kasar Sin da kayan aikin likitanci;
3. R&D, samarwa da siyar da manyan samfuran kiwon lafiya; kuma
4. Ayyukan likita da kula da lafiya, kula da lafiya da fensho da sauran jarin masana'antar kiwon lafiya, da dai sauransu. 

Ƙungiyar tana da jimillar magunguna 25 kamfanonin masana'antu da cibiyoyi (ciki har da rassa 3, kamfanoni 19 da ke rike da rassa 3 da kamfanonin hadin gwiwa 12), gami da XNUMX na kasar Sin da aka karrama. pharmaceutical kamfanonin da kamfanoni na karni na 10; Keɓantattun samfuran magunguna na kasar Sin Akwai ƙa'idodi sama da 100 (ciki har da masu hannun jari da kamfanonin haɗin gwiwa).

• Haraji: CNY biliyan 79

Bayan shekaru na ƙwararrun gini da haɓaka haɓakawa, ƙungiyar a hankali ta kafa manyan sassan kasuwanci guda huɗu: "Babban Magungunan Kudancin", "Babban Lafiya", "Babban Kasuwanci" da "Babban Likita", da kuma "Kasuwancin E-kasuwanci", " Babban Kuɗi" da "Na'urorin Likita". “Sabbin tsari guda uku. 

2. China National Accord Medicines Corporation

China National Accord Medicines Corporation Ltd. kamfani ne na kasar Sin wanda ke tsunduma cikin harkokin hada-hadar magunguna, dillalai da masana'antu.

Babban samfuran Kamfanin sun haɗa da shirye-shiryen rigakafi, iko allura, maganin rigakafi Active Pharmaceutical Ingredients (APIs), magungunan tsarin numfashi da cututtukan zuciya da jijiyoyin jini, da sauransu.

• Haraji: CNY biliyan 67

Kamfanin yana kuma shiga cikin samar da kayan aiki da sabis na ajiya, sabis na ba da haya da sabis na horo, da sauransu. Kamfanin yana rarraba kayayyakinsa musamman a kasuwannin cikin gida.

3. Ma'aikatar harhada magunguna ta kasar Sin

China National Pharmaceutical and Healthcare Industry Co., Ltd. wani kamfani ne da aka jera a kan kasuwar hada-hadar hannayen jari ta Shanghai (takaice hannun jari: China National Pharmaceutical; lambar hannun jari: 600056).

Mai kula da hannun jari shine China General Technology (Group) Holdings Co., Ltd. Tare da babban jari na Yuan biliyan 1.068, kamfanin yana ɗaya daga cikin manyan kamfanoni uku na tsakiya waɗanda ke da babban kamfani. masana'antar harhada magunguna a matsayin babban kasuwancinsa.

• Haraji: CNY biliyan 56

Magabacin kamfanin harhada magunguna na kasar Sin shi ne kamfanin samar da magunguna da kayayyakin kiwon lafiya na kasar Sin a karkashin tsohuwar ma'aikatar cinikayya da hadin gwiwar tattalin arziki ta kasar Sin a shekarar 1984.

Ita ce mai kula da harkar magunguna da kayayyakin kiwon lafiya na kasa baki daya. Ya shiga rukunin fasaha na China General Technology a 1999 kuma ya zama ɗaya tilo na ƙungiyar bayan sake fasalin aikin likitanci. dukiya cikin group.

4. Nanjing Pharmaceutical Factory

Nanjing Pharmaceutical Factory Co. Ltd an fara samo shi a cikin 1935 kuma yana ɗaya daga cikin manyan masana'antun masana'antar harhada magunguna ta ƙasa. Bayan sake tsara kadara ta Shenzhen Anyuan Group Investment Group a 2000, Nanjing Pharmaceutical Factory ya zama wani babban sikelin Pharmaceutical kungiyar da integrates R&D, samarwa da kuma sayar da APIs (Active Pharmaceutical Sinadaran), formulations da tsaka-tsaki.

Sabuwar gudanarwa ta daidaita layin samfurin da dabarun ci gaban kamfani, bin tsarin falsafar "kula da rayuwa, sadaukar da kai ga lafiyar lafiya", Factoty na Nanjing Pharmaceutical Factoty zai ba da gudummawa sosai don inganta rayuwar ɗan adam da lafiyar ɗan adam a ƙarƙashin jagorancin "sakewa da gyarawa da kuma inganta lafiyar ɗan adam." bidi'a".

• Haraji: CNY biliyan 39

Tushen masana'antu na APIs, wanda ke cikin Nanjing Chemical Industrial Park, yana da masana'antar samarwa guda shida da suka haɗa da bita na musamman da masu fa'ida da yawa. Tushen ya wuce binciken GMP na ƙasa da na ƙasa sau da yawa. Kusan nau'ikan APIs ashirin ana siyar da su zuwa kasuwannin cikin gida da na ketare.

The formulations masana'antu tushe locates a Nanjing Xingang Tattalin Arziki & Fasaha Development Zone, tare da allura bitar (antineoplastic tushen foda da kuma ruwa allura) da kuma ƙwararrun shirye-shiryen baka (Allunan, capsules da granules). Tushen ya wuce binciken GMP na ƙasa sau da yawa. Ana sayar da shirye-shirye sama da ashirin a duk faɗin China.

5. Yunnan Baya

An kirkiro Yunnan Baiyao a shekara ta 1902, sanannen alamar kasuwanci a kasar Sin, kuma yana cikin rukunin farko na kamfanonin kirkire-kirkire na kasa. Shahararriyar alama ce ta kasar Sin da ta karrama lokaci a gida da waje.

A shekarar 1971, an kafa masana'anta bisa ga umarnin firaministan kasar Zhou Enlai. A cikin 1993, an jera shi a kan kasuwar Shenzhen Stock Exchange a matsayin kamfani na farko da aka jera a Yunnan.

• Haraji: CNY biliyan 32
• An kafa: 1902

Kamfanin ya kasu kashi hudu manyan sassa hudu: magunguna, kayayyakin kiwon lafiya, albarkatun magungunan gargajiya na kasar Sin, da kuma kayan aikin magunguna.

Kowane sashe yana da 'yancin kai kuma yana tallafawa juna, yana tasowa daga kiwo, dasa, bincike da haɓakawa, masana'antu zuwa tsarin ƙimar kasuwa na dukkan sassan masana'antu na samfuran lafiya da sabis suna samar da yanayin yanayin tattalin arziƙi tare da haɗin gwiwar manyan masana'antu da masu amfani da juna. ci gaban sassa da yawa.

6. Shandong Realcan Pharmaceutical Group

Shandong Realcan Pharmaceutical Group kamfani ne da ke siyar da magunguna, na'urorin likitanci, da kayan aikin likita ga cibiyoyin kiwon lafiya a duk faɗin ƙasar. Har ila yau, tana da manyan sassan sabis guda takwas da suka haɗa da fasahar kuɗi, likitancin gargajiya na kasar Sin, likitancin dijital, masana kimiyyar harhada magunguna, ƙwararrun dabaru, na'urar R&D da samarwa, gano likitanci, da haɗa na'urori. Mai bada sabis na likita.

An kafa kamfanin Shandong Realcan Pharmaceutical Group a ranar 21 ga Satumba, 2004 tare da babban jari na Yuan biliyan 1.5. Tana da rassa sama da 130 da sama da 12,000 ma'aikata. 

• Haraji: CNY biliyan 28
• An kafa: 2004
• Ma'aikata: 12000

An jera kamfanin a kasuwar Shenzhen A-share a watan Yuni 2011 tare da lambar hannun jari mai lamba 002589. Cibiyar sadarwar tallace-tallace ta shafi larduna da biranen 31 a fadin kasar, wanda ke ba da sabis na kiwon lafiya fiye da 42,000 kai tsaye, kuma kasuwancinsa ya shafi kusan dukkanin masana'antun gida da na waje a sama. girman da aka zaba.

7. Jiangsu Hengrui Pharmaceutical

Jiangsu Hengrui Pharmaceutical Co., Ltd. wani kamfani ne na magunguna da kuma kamfanin kiwon lafiya wanda ke aiki a cikin ƙididdiga na harhada magunguna da R&D mai inganci, samarwa da haɓakawa.

An kafa ta a cikin 1970 kuma an jera ta a kasuwar hada-hadar hannayen jari ta Shanghai a shekarar 2000. Ya zuwa karshen shekarar 2019, tana da ma'aikata sama da 24,000 a duk duniya. Sananniya ce ta cikin gida da ke samar da magungunan cutar kansa, magungunan fiɗa da kuma abubuwan da suka bambanta, sannan kuma shine jagorar ƙungiyar National Anti-tumor Drug Technology Innovation Industry-Jami'a-Research Alliance.

• Haraji: CNY biliyan 26

Ta kafa Cibiyar Binciken Fasahar Fasahar Magunguna ta Ƙasa da Target da kuma tashar bincike bayan kammala karatun digiri. A shekarar 2019, kamfanin ya samu kudin shigar da ya kai yuan biliyan 23.29 da harajin Yuan biliyan 2.43, kuma an zabe shi cikin jerin sunayen kamfanonin harhada magunguna na duniya na TOP50, inda ya ke matsayi na 47.

A cikin 'yan shekarun nan, kamfanin ya zuba jari game da 15% na tallace-tallace a cikin bincike da kudaden ci gaba. A shekarar 2019, ta zuba jarin Yuan biliyan 3.9 a fannin bincike da asusun raya kasa. lissafin don 16.7% na kudaden shiga na tallace-tallace. 

Kamfanin ya kafa cibiyoyin R&D ko rassa a Amurka, Turai, Japan, da China, kuma ya gina ƙungiyar R&D sama da mutane 3,400, gami da likitoci sama da 2,000, masters da kuma masu dawowa sama da 200. A cikin 'yan shekarun nan, kamfanin ya gudanar da manyan ayyuka na musamman na 44 na kasa, kuma yana da magunguna na 6, irecoxib, apatinib, thiopefilgrastim, pirotinib, carrelizumab da toluene Remazolam acid an amince da su don tallace-tallace, wani nau'i na magunguna masu mahimmanci suna ƙarƙashin ci gaban asibiti, kuma ana haɓaka adadin sabbin magunguna a asibiti a Amurka. 

Kamfanin ya nemi jimillar haƙƙin ƙirƙira na cikin gida guda 894, yana da ingantaccen haƙƙin ƙirƙira na gida guda 201, da haƙƙin mallaka na ƙasashen waje 286 kamar Turai, Amurka da Japan. Babban fasahar mallakarta ta sami lambar yabo ta ci gaban kimiyya da fasaha ta ƙasa mai aji biyu na biyu da lambar yabo ta China Patent Gold Award.

8. Renfu Pharmaceutical Group

Renfu Pharmaceutical Group Co., Ltd an kafa shi a cikin 1993 kuma an jera shi akan kasuwar hada-hadar hannayen jari ta Shanghai a 1997 (600079.SH). Jagoran masana'antar harhada magunguna ta lardin Hubei, masana'antar harhada magunguna ta kasar Sin ta fi 100, sana'ar nuna kirkire-kirkire a fannin kimiyya da fasaha ta kasa.

Kamfanin yana bin dabarun "kasancewa jagora a cikin kasuwar hada magunguna kashi”, kuma ya kafa babban matsayi a cikin maganin sa barci na cikin gida, analgesics, masu kula da haihuwa, magungunan Uygur da sauran sassan sassan; a lokaci guda, yana haɓaka kasuwancin harhada magunguna da ɗorewa kuma yana haɓaka tsarin haɗin gwiwar duniya. , Don cimma R&D na duniya, kasuwa da tsarin masana'antu a Amurka da Afirka.

A matsayin "Cibiyar Fasahar Kasuwancin Kasuwanci ta Kasa" da "National Major New Drug Development Project Undertaking Unit", kamfanin ya dage kan daukar R&D a matsayin na gaba, kuma yana kan gaba wajen saka hannun jarin R&D na cikin gida da kamfanonin harhada magunguna da sabon ci gaban R&D.

An kafa ta ne tare da hadin gwiwar Cibiyar Nazarin Kiwon Lafiyar Soja ta kasar Sin. Junke Optics Valley Innovative Drug R&D Center" ya jagoranci kafa "Hubei Biomedical Industry Technology Research Institute", sadaukar domin gina wani gida-aji na farko-aji sabon magani R&D masana'antu dandamali.

9. Sichuan Kelun Pharmaceutical

Kelun ƙungiya ce ta musamman kuma ƙwararrun masana harhada magunguna da ke da kudaden tallace-tallace na sama da yuan biliyan 40 a shekara. Ya hada da Sichuan Kelun Pharmaceutical Co., Ltd., Sichuan Kelun Pharmaceutical Research Institute Co., Ltd., Klus Pharma Inc. (Kelun, Amurka), da KAZ Pharmaceutical Co., Ltd. (Kazakhstan Kelun), Sichuan Kelun Pharmaceutical Trading Co., Ltd. ., Ltd da kamfanoni sama da 100 a gida da waje. 

• Haraji: CNY biliyan 16

A shekarar 2017, Kelun ya zama na 155 a cikin manyan kamfanonin masana'antu 500 na kasar Sin, kuma cikakken karfinsa ya kasance a cikin sahu uku na farko a masana'antar harhada magunguna ta kasar Sin. A cikin 2018, an ba da Kelun a matsayin kamfani na zanga-zanga guda ɗaya a masana'antar masana'antu ta hanyar fa'idodinsa na duniya a cikin manyan allurai. A cikin 2020, Kelun ya sami lambar yabo ta Kasuwancin Ƙirƙirar Ƙirƙirar Fasaha ta Ƙasa.

Kamfanin Sichuan Kelun Pharmaceutical Co., Ltd ya samu nasarar jera shi a kasuwar hada-hadar hannayen jari ta Shenzhen a watan Yunin shekarar 2010. Da zarar an bayyana shi a bainar jama'a, nan da nan Kelun ya kaddamar da dubun dubatan biliyoyin shirin saka hannun jari na masana'antu tare da fara aiwatar da dabarun ci gaba na "ci gaba guda uku da aka kulla. , sabon ci gaba”.

10. Chongqing Zhifei Kayayyakin Halittu

Chongqing Zhifei Biological Products Co., Ltd. ("Zhifei" ko "Kamfanin" a takaice) yana da kasancewarsa a masana'antar samfuran halitta a cikin 2002. Kamfanin ya sami kudin shiga aiki na RMB10.59 biliyan a cikin 2019 tare da tallafin kusan kusan RMB. Ma'aikata 3,000 bisa ga babban jarin da ya yi rajistar RMB1.6 biliyan da jimillar kadarorin RMB13.6 biliyan.

A watan Satumba na 2010, an jera Zhifei a kan kasuwar hada-hadar hannayen jari ta Shenzhen (lambar hannun jari: 300122), ta zama kamfani na farko da ke gudanar da allurar rigakafin cutar a ChiNext. Zhifei yana da rassa guda biyar na gaba ɗaya da wani reshen hannun jari na haɗin gwiwa, wanda Beijing ZhifeiLvzhu Biopharmaceutical Co., Ltd. da Anhui ZhifeiLongcom Biopharmaceutical Co., Ltd. sabbin kamfanoni ne na fasaha.

• Haraji: CNY biliyan 14

Samfurori na Kasuwanci na Kamfanin sun haɗa da Recombinant Mycobacterium Tuberculosis Fusion Protein (EC) (Ekear®), Haemophilus Influenzae Type b Vaccine (XiFeiBei®), Group ACYW₁₃₅ Meningococcal Polysaccharide Vaccine (Menwayc®), Mycobacterium Vaccae don allura (Vaccae®), Meningococcal Group A da Rukunin C Polysaccharide Conjugate Vaccine (Mening A Con®), da sauran samfuran da aka haɓaka masu zaman kansu. A halin yanzu, Zhifei shine kadai mai rarraba alluran rigakafin Merck Sharp & Dohme (MSD) kamar HPV4 (Gradasil), HPV9 (Gradasil 9), rigakafin rotavirus 5-valent (Rotateq), rigakafin ciwon huhu 23 (Pneumovax 23), Hepatitis. Alurar rigakafi (Vaqta).